Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
New budgeting challenges require flexible thinking. This brief guide offers strategies to adjust your plan while maintaining financial stability.
24,577 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
Addy AI announced a strategic integration with ICE Mortgage Technology’s Encompass system to automate loan officer wo...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
Investors are eyeing space stocks, but SpaceX remains private while Rocket Lab trades on the public market. This guid...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
Rumors are swirling about meta platforms reportedly getting into prediction markets. This potential pivot could redef...
NVIDIA unveils a robotics AI model aimed at real-world manipulation tasks, signaling a potential market catalyst for ...
Charles Schwab stock bumping higher today caught investors' attention as May metrics showed record asset inflows. Thi...
A surge of mega IPOs in 2026 is minting new fortunes. Melinda French Gates’ advice for these newcomers centers on gen...
AI infrastructure has reshaped markets, but not every stock fits every investor. This guide explains what CoreWeave d...
Liquidity squeezes in major private credit funds put the trillion private credit boom under stress. Bitcoin could be ...